$908M
$46.2 Million
0.01% of portfolio
1,500
Q3 2024
New
$8.58B
$58.8 Million
0.01% of portfolio
600
Q3 2024
New
$8.54B
$65 Million
0.01% of portfolio
800
Q3 2024
New
$4.46B
$54.7 Million
0.01% of portfolio
400
Q2 2024
Reduced 75.0%
$3.14B
$33.3 Million
0.01% of portfolio
400
Q1 2024
Added 2,250.0%
$2.43B
$48.2 Million
0.01% of portfolio
28,000
Q3 2024
New
$4.03B
$38.3 Million
0.01% of portfolio
800
Q3 2024
New
$26.6B
$53 Million
0.01% of portfolio
400
Q2 2024
Reduced 50.0%
$764M
$24.6 Million
0.01% of portfolio
1,100
Q2 2024
Reduced 81.82%
$1.17B
$32.1 Million
0.01% of portfolio
400
Q1 2024
Added 175.0%
$3.68B
$64.9 Million
0.01% of portfolio
900
Q1 2024
Reduced 88.89%
$2.76B
$36.7 Million
0.01% of portfolio
400
Q2 2024
Reduced 25.0%
$768M
$27.1 Million
0.01% of portfolio
1,800
Q2 2024
Reduced 77.78%
$2.67B
$60.6 Million
0.01% of portfolio
900
Q2 2024
Reduced 33.33%
$1.06B
$43.7 Million
0.01% of portfolio
5,700
Q2 2024
Reduced 82.46%
$1.36B
$52 Million
0.01% of portfolio
2,800
Q3 2024
New
$2.24B
$50.5 Million
0.01% of portfolio
300
Q3 2024
New
$15.6B
$62.1 Million
0.01% of portfolio
400
Q2 2024
Added 125.0%
$644M
$37.1 Million
0.01% of portfolio
2,000
Q2 2024
Reduced 85.0%
$33.2B
$49 Million
0.01% of portfolio
400
Q3 2024
New
$3.65B
$64.4 Million
0.01% of portfolio
2,000
Q1 2024
Added 120.0%
-
$48.3 Million
0.01% of portfolio
-
Q3 2024
New
$31.9B
$50.7 Million
0.01% of portfolio
800
Q1 2024
Added 762.5%
$9.92B
$66.4 Million
0.01% of portfolio
400
Q3 2024
New
$325M
$35.7 Million
0.01% of portfolio
3,400
Q3 2024
New
$2.16B
$53.5 Million
0.01% of portfolio
3,400
Q2 2024
Reduced 73.53%
$6.82B
$30.2 Million
0.01% of portfolio
600
Q3 2024
New
Rigel Pharmaceuticals Inc
-
$43.7 Million
0.01% of portfolio
-
Q3 2024
New
$57.9B
$53.2 Million
0.01% of portfolio
300
Q3 2024
New
$8.84B
$42.1 Million
0.01% of portfolio
300
Q3 2024
New
$15.6B
$48.4 Million
0.01% of portfolio
400
Q1 2024
Added 325.0%
$0
$56 Million
0.01% of portfolio
2,000
Q1 2024
Reduced 55.0%
$7.77B
$43.7 Million
0.01% of portfolio
300
Q2 2024
Added 33.33%
$1.38B
$33.6 Million
0.01% of portfolio
800
Q2 2024
Reduced 87.5%
$141M
$23.6 Million
0.01% of portfolio
12,000
Q3 2024
New
$5.41B
$37.3 Million
0.01% of portfolio
400
Q2 2024
Added 950.0%
$2.83B
$48.1 Million
0.01% of portfolio
600
Q2 2024
Reduced 66.67%
$104M
$23.6 Million
0.01% of portfolio
24,900
Q1 2024
Added 285.5%
$12.1B
$47.4 Million
0.01% of portfolio
600
Q2 2024
Added 33.33%
$424M
$29.2 Million
0.01% of portfolio
6,400
Q2 2024
Reduced 78.13%
$4.42B
$32.2 Million
0.01% of portfolio
400
Q2 2024
Reduced 25.0%
$504M
$66 Million
0.01% of portfolio
46,500
Q3 2024
New
$600M
$66.3 Million
0.01% of portfolio
4,700
Q2 2024
Reduced 82.98%
-
$62.5 Million
0.01% of portfolio
-
Q1 2024
Reduced 90.0%
$5.33B
$60 Million
0.01% of portfolio
1,500
Q2 2024
Reduced 20.0%
$1.85B
$44.2 Million
0.01% of portfolio
3,600
Q3 2024
New
$963M
$40.1 Million
0.01% of portfolio
1,200
Q2 2024
Reduced 75.0%
$14.8B
$33.1 Million
0.01% of portfolio
300
Q2 2024
Reduced 33.33%
$19.1B
$59.4 Million
0.01% of portfolio
800
Q2 2024
Reduced 87.5%
$5.8B
$35.2 Million
0.01% of portfolio
900
Q2 2024
Reduced 33.33%